Literature DB >> 908743

Persistence of serum antibody to hepatitis B core antigen.

B G Hansson.   

Abstract

The purpose of the present study was to measure the amount of antibody to hepatitis B core antigen (anti-HBc) in different populations by the immunoelectroosmophoresis method. High titers of anti-HBc, up to 1/4,096, were found in the acute stage of hepatitis B virus infections and in the chronic carrier state of hepatitis B surface antigen. In cases of acute hepatitis the anti-HBc titers gradually declined to low levels but persisted for the observation time of 5 to 6 years. Individuals positive for antibodies to hepatitis B surface and core antigens selected from a Swedish "normal" population showed still lower anti-HBc titers, indicating that the hepatitis B infection had occurred earlier. The anti-HBc titers in sera drawn at intervals of 4 years from a group of hemophilia patients may indicate previous infection with replicating hepatitis B virus rather than immunization with noninfectious hepatitis B core antigen material.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 908743      PMCID: PMC274741          DOI: 10.1128/jcm.6.3.209-211.1977

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Antibody to hepatitis-B-virus core in man.

Authors:  J H Hoofnagle; R J Gerety; L F Barker
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

2.  Improved technique for detecting Australia antigen by immunoelectroosmophoresis.

Authors:  B G Hansson; T Johnsson
Journal:  Vox Sang       Date:  1971-12       Impact factor: 2.144

3.  Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen.

Authors:  S Krugman; J H Hoofnagle; R J Gerety; P M Kaplan; J L Gerin
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

4.  Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication.

Authors:  J H Hoofnagle; R J Gerety; L Y Ni; L F Barker
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

5.  Hepatitis and clotting-factor concentrates.

Authors:  C K Kasper; S A Kipnis
Journal:  JAMA       Date:  1972-07-31       Impact factor: 56.272

6.  A study of Australia-antigen-positive blood donors and their recipients, with special reference to liver histology.

Authors:  V Reinicke; E Dybkjaer; H Poulsen; O Banke; K Lylloff; E Nordenfelt
Journal:  N Engl J Med       Date:  1972-04-20       Impact factor: 91.245

7.  Transmission of viral hepatitis, type B, by plasma derivatives.

Authors:  L F Barker; J H Hoofnagle
Journal:  Dev Biol Stand       Date:  1974

8.  New antigen-antibody system in Australia-antigen-positive hepatitis.

Authors:  J D Almeida; D Rubenstein; E J Stott
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321

9.  Subtypes of Hepatitis B Antigen in Blood Donors and Post-transfusion Hepatitis: Clinical and Epidemiological Aspects.

Authors:  S Iwarson; L Magnius; A Lindholm; P Lundin
Journal:  Br Med J       Date:  1973-01-13

10.  Antibody to hepatitis B core antigen.

Authors:  J H Hoffnagle; R J Gerety; L F Barker
Journal:  Am J Med Sci       Date:  1975 Jul-Aug       Impact factor: 2.378

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.